We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxaco | LSE:OXA | London | Ordinary Share | GB00B29YYY86 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/6/2014 10:59 | A new milestone achieved with today's RNS. | michaelx105 | |
19/6/2014 17:47 | Just had a quick look at this. Does anyone know why Hylomar is not a customer for Onto? | supernumerary | |
18/6/2014 12:06 | 40% spread...geez! | michaelx105 | |
17/6/2014 11:25 | Out now 17 June 2014 OXFORD ADVANCED SURFACES GROUP PLC Preliminary Results for the Year Ended 31 December 2013 Look quite encouraging. | rrr | |
13/6/2014 09:28 | Why do you say that? Any special reason? | rrr | |
13/6/2014 08:26 | Looks as if there may be life in the old dog yet.............. | esteban1 | |
12/6/2014 08:56 | Continuing to fall - No sign of any sales traction - Almost looks as though Mr Market has decided this business model/product technology will not be a success. Have been watching as sold out earlier - Originally -from memory - a MW Tip Any contrary information ? | pugugly | |
20/5/2014 19:50 | Found this:http://time.com | michaelx105 | |
12/5/2014 10:55 | Nice buy, one of the largest I've seen here...more please. | michaelx105 | |
22/4/2014 15:24 | Graphene made in a kitchen blender: | rrr | |
08/4/2014 13:24 | As you say Michael, graphene is an extraordinary material and if (as OXA obviously hope) the Onto technology can be used to modify it as required, without negating its valuable characteristics, and relatively easily on an industrial scale, that should be very valuable. Having invested in other hi-tech companies which also had exciting ideas but which came to nothing for one reason or another I'm rather well aware that commercial success is not guaranteed! rrr | rrr | |
08/4/2014 12:01 | Agreed rrr...I just hope their marketing dept. are as good as their chemists...there are competitors out there that understand the possibilities of this material.http://www. | michaelx105 | |
04/4/2014 14:02 | Thanks Michael, more or less what I think myself, worth holding, quality science - but obviously not without risk! | rrr | |
04/4/2014 13:36 | Interesting post about OXA here:http://www.safe | michaelx105 | |
01/4/2014 13:57 | I just bought in...that was a buy not a sell | michaelx105 | |
17/3/2014 13:04 | There are some first rate chemists behind OXA so I agree this is good. Turning ideas into products and sales seems to be the hard bit. | rrr | |
17/3/2014 12:35 | Yep graphene could be massive so it sounds like a good area to focus on | count chris | |
17/3/2014 08:56 | Potentially exciting RNS re graphene functionalisation. | rrr | |
03/2/2014 10:14 | Good to see a positive piece of news. From that website: "Sun Chemical, a member of the DIC group, is the world's largest producer of printing inks and pigments' | rrr | |
26/1/2014 08:01 | IMHO, the latter panamabob2, but would be delighted to be proved wrong ! | multibagger | |
25/1/2014 18:43 | Either they are very confident or its an act of desparation. At first sight the market seemed to be quite enthused,but time will tell. | panamabob2 | |
24/1/2014 10:07 | Pug I think that we both saw the writing on the wall some time back and got out accordingly. I just hope for OXA's sake that they have thought through this latest marketing strategy very thoroughly and will target potential customers carefully at the right levels and as PART of the sales qualification cycle. This is most important otherwise the initiative may well fail as I've already outlined above in 460. | vasilis | |
24/1/2014 09:37 | Vasillis:> Excellent analysis. I am tempted to copy to the coy with a strong suggestion that you are appointed as a non Exec Director - but as do not hold having sold out at a significantly higher price this would be like rubbing salt in the wound !!! | pugugly | |
24/1/2014 08:50 | From a hard-nosed business perspective the most significant bit is this IMO :- 'The development packs will enable customers to quickly assess the system in their own labs and help shorten the time between assessment, pilot trial and the supply of a commercial product by OAS.' I interpret that to mean something along the lines of - 'We have problems kicking off the sales cycle so we are offering customers to trial the product for free in their labs and then hope we can progress the sales cycle from there.' IF potential customers have requested such trials then there is some logic to this marketing strategy. However, I've just re-read the RNS and I cannot see anything that suggests such a request coming from customers. Therefore if this is simply a supplier led initiative then it may well be taken up within the labs on a 'nothing to lose' basis but may wither on the vine at that point unless there is targeted customer focus at senior level to keep selling the benefits of the business case if lab trials are successful and justify further pilot trials from the customers viewpoint. I trust that OXA are aware that it is far more complicated than a 'try and buy' exercise and specific sales skills are required to handle such an exercise. | vasilis |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions